Immunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia's US business |
| March 28, 2022 | March 2022 Bond Updates |
|
LUND, Sweden, March 28, 2022 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Jeff Borcherding as CEO of its US subsidiary Immunovia, Inc. He joins from Myriad Genetics, one of the leading diagnostic companies in the US, where he was Chief Marketing Officer. Jeff will be... |
| View more at: https://www.prnewswire.com:443/news-releases/immunovia-appoints-jeff-borcherding-previously-chief-marketing-officer-at-myriad-genetics-to-lead-immunovias-us-business-301511453.html |
| Related News |